Signal active
Investment Firm
Overview
Adage Capital Management is a Boston-based $8.9B Money Management firm focused on managing S&P 500 assets predominantly for Endowments and Foundations such as Harvard University, Northwestern University, Dartmouth College, the American Red Cross and the Getty Foundation. Adage and its predecessor, the Select Equity Group at the Harvard Management Company, has outperformed the S&P index in each of the last 15 years by an average of 3.5%.
The fund is run by Phill Gross, who prior to founding Adage, was a Healthcare and Retail analyst, equity research director and partner at the Harvard Management Company for 18 years..
Highlights
2001
Financial Services
11-50
122
10
87
Late Stage Venture, Private Equity, Early Stage Venture
Government Office
Location
United States, North America
Contact Information
Social
Profile Resume
Adage Capital Management, established in 2001 and headquartered in United States, North America., specializes in Late Stage Venture, Private Equity, Early Stage Venture investments across Biotechnology, Health Care, Pharmaceutical, Medical, Venture Capital, Finance, Business Development, Photography, Angel Investment, Financial Services. The organization boasts a portfolio of 122 investments, with an average round size of $118.7M and 87 successful exits. Their recent investments include Concert Pharmaceuticals, Flagship Pioneering, Brookside Capital, Skyline Ventures, Three Arch Partners. The highest investment round they participated in was $1602.0B. Among their most notable exits are Concert Pharmaceuticals and Flagship Pioneering. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Investment portfolio
122
24
10
87
Investments
122
Annouced Date | Organization Name | Industry | Money Raised |
---|---|---|---|
Apr 16, 2024 | - | - | 280.0M |
Apr 18, 2024 | Benitec Ltd | Biotechnology | 40.0M |
May 03, 2024 | Abeona Therapeutics | Biotechnology | 75.0M |
Jun 14, 2024 | Disc Medicine | Biotechnology | 178.0M |
Exits
87
Funding Timeline
122
0
1
Funding Rounds
122
Adage Capital Management has raised 122 rounds. Their latest funding was raised on Jun 14, 2024 from a Post-IPO Equity - Disc Medicine round.
Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
---|---|---|---|---|
Apr 16, 2024 | Post-IPO Equity - Cullinan Therapeutics | - | 280.0M | - |
Apr 18, 2024 | Post-IPO Equity - Benitec Ltd | - | 40.0M | - |
May 03, 2024 | Post-IPO Equity - Abeona Therapeutics | - | 75.0M | - |
Jun 14, 2024 | Post-IPO Equity - Disc Medicine | - | 178.0M | - |
Investors
0
There is no funding round available on this profile
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
Annouced Date | Fund Name | Money Raised |
---|---|---|
May 10, 2013 | OTPPLESS | 1.0M |
May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
Recent Activity
There is no recent news or activity for this profile.